Cannabotech Ltd
CannaboTech Ltd engages in developing cannabinoid-based medication and healthcare products. It provides drugs for various indications; personalized cannabinoid-based products; and CBD-based skincare and food-supplement products. The company was incorporated in 2019 and is based in Rishon LeZion, Israel.
Cannabotech Ltd (CNTC) - Net Assets
Latest net assets as of : ILA- ILA
Based on the latest financial reports, Cannabotech Ltd (CNTC) has net assets worth ILA- ILA as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA-) and total liabilities (ILA-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Cannabotech Ltd - Net Assets Trend (None–None)
This chart illustrates how Cannabotech Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cannabotech Ltd (None–None)
The table below shows the annual net assets of Cannabotech Ltd from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Cannabotech Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Cannabotech Ltd Competitors by Market Cap
The table below lists competitors of Cannabotech Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Quality Hospitality Leasehold Property Fund
BK:QHOP
|
$900.66 |
|
Gaussin SA
MU:1KK1
|
$901.67 |
|
Medicofarma Biotech S.A.
WAR:MDB
|
$901.68 |
|
EUNISELL INTERLINKED PLC
XNSA:EUNISELL
|
$901.82 |
|
E-COMMODITIES HOLDINGS
F:WWY1
|
$899.40 |
|
LINIF
OTCQB:LINIF
|
$898.29 |
|
Service Textile
KAR:SERT
|
$897.57 |
|
FinEx Metals Ltd.
V:FINX
|
$896.54 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cannabotech Ltd's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Cannabotech Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Cannabotech Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Cannabotech Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $59,527,500
- Average return on equity (ROE) among peers: -3262.51%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cannabotech Ltd (CNTC) | ILA- | N/A | N/A | $899.93 |
| Canzon Israel Ltd (CNZN) | $11.02 Million | -7.32% | 0.37x | $18.43K |
| Intercure (INCR) | $256.20 Million | -2.30% | 0.10x | $367.38K |
| Rekah Pharmaceutical Industry Ltd (REKA) | $64.15 Million | 8.02% | 3.34x | $385.28K |
| Seach Medical Group Ltd (SEMG) | $25.69 Million | 31.20% | 0.30x | $278.78K |
| Together Startup Network Ltd (TGTR) | $-12.00K | 0.00% | 0.00x | $124.45K |
| Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) | $108.00K | -19604.63% | 64.89x | $75.63K |